Abstract
Introduction Inadequate measles vaccination coverage leads to outbreaks that affect the pediatric population in Peru. The aim of this study was to evaluate sociodemographic inequalities related to the coverage and compliance in the two-dose measles vaccination schedule among Peruvian children in 2023.
Methods An analytical cross-sectional study was conducted using data from a national Peruvian survey. Mothers aged 15 to 49 with children aged 12 to 59 months were included. Sociodemographic and health characteristics of the mother and child were considered sources of inequality. Prevalence ratios (PR) were calculated to measure the characteristics associated with adherence to the measles vaccination schedule. Inequality analysis was assessed using the Erreygers Concentration Index (ECI).
Results A total of 8,148 households were evaluated. Vaccination coverage was identified as 85.9% (95%CI: 94.7 – 87.1) for the first dose and 53.9% (95%CI: 52.1 – 55.7) for the second dose. In the inequality analysis, mothers with no education (CI: -0.57), aged 15 to 17 years (CI: -0.38), residing in the jungle (CI: -0.41) or highlands (CI: -0.26), and without health insurance (CI: -0.01) showed greater inequality in adherence to the vaccination schedule. Additionally, adherence to growth and development check-ups in infants was a source of inequality (CI: -0.09).
Conclussion Measles vaccination coverage did not reach the minimum values required to prevent outbreaks in Peru. The factors contributing to inequality in vaccination coverage included education level, age, region of residence, area of residence, health insurance status, and adherence to growth and development check-ups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Self-funded
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data obtained from the National Institute of Statistics and Informatics (or INEI, in Spanish) platform: https://proyectos.inei.gob.pe/microdatos/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data obtained from the National Institute of Statistics and Informatics (or INEI, in Spanish) platform: https://proyectos.inei.gob.pe/microdatos/
